Wang R, Hastings W, Saliba J, Bao D, Huang Y, Maity S
ACS Nano. 2024; 19(1):73-100.
PMID: 39704725
PMC: 11752498.
DOI: 10.1021/acsnano.4c11505.
Topriceanu C, Moon J, Raja A, Captur G, Ho C
Circ Genom Precis Med. 2024; 17(4):e004580.
PMID: 38910555
PMC: 11335455.
DOI: 10.1161/CIRCGEN.124.004580.
Schlittler M, Pramstaller P, Rossini A, De Bortoli M
Int J Mol Sci. 2023; 24(19).
PMID: 37834293
PMC: 10573356.
DOI: 10.3390/ijms241914845.
Lu J, Ren J, Liu J, Lu M, Cui Y, Liao Y
Cell Prolif. 2023; 57(3):e13557.
PMID: 37766635
PMC: 10905351.
DOI: 10.1111/cpr.13557.
Mi K, Wu S, Lv C, Meng Y, Yin W, Li H
Front Cardiovasc Med. 2023; 10:1190181.
PMID: 37645523
PMC: 10461399.
DOI: 10.3389/fcvm.2023.1190181.
From Genomics to Metagenomics in the Era of Recent Sequencing Technologies.
Benz S, Mitra S
Methods Mol Biol. 2023; 2649:1-20.
PMID: 37258855
DOI: 10.1007/978-1-0716-3072-3_1.
Different phenotype of left atrial function impairment in patients with hypertrophic cardiomyopathy and hypertension: comparison of healthy controls.
Li H, Wang H, Wang T, Jin C, Lu M, Liu B
Front Cardiovasc Med. 2023; 10:1027665.
PMID: 37234371
PMC: 10206117.
DOI: 10.3389/fcvm.2023.1027665.
MYH7 in cardiomyopathy and skeletal muscle myopathy.
Gao Y, Peng L, Zhao C
Mol Cell Biochem. 2023; 479(2):393-417.
PMID: 37079208
DOI: 10.1007/s11010-023-04735-x.
Transforming Growth Factor-β Analysis of the VANISH Trial Cohort.
Kim Y, Mastali M, Van Eyk J, Orav E, Vissing C, Day S
Circ Heart Fail. 2023; 16(4):e010314.
PMID: 36999957
PMC: 10121916.
DOI: 10.1161/CIRCHEARTFAILURE.122.010314.
A maladaptive feedback mechanism between the extracellular matrix and cytoskeleton contributes to hypertrophic cardiomyopathy pathophysiology.
Viola H, Richworth C, Solomon T, Chin I, Cserne Szappanos H, Sundararaj S
Commun Biol. 2023; 6(1):4.
PMID: 36596888
PMC: 9810744.
DOI: 10.1038/s42003-022-04278-9.
Contemporary Therapies and Future Directions in the Management of Hypertrophic Cardiomyopathy.
Packard E, de Feria A, Peshin S, Reza N, Owens A
Cardiol Ther. 2022; 11(4):491-507.
PMID: 36243823
PMC: 9652179.
DOI: 10.1007/s40119-022-00283-5.
Genetic inhibition of serum glucocorticoid kinase 1 prevents obesity-related atrial fibrillation.
Bapat A, Li G, Xiao L, Yeri A, Hulsmans M, Grune J
JCI Insight. 2022; 7(19).
PMID: 35998035
PMC: 9675459.
DOI: 10.1172/jci.insight.160885.
Left atrial dysfunction may precede left atrial enlargement and abnormal left ventricular longitudinal function: a cardiac MR feature tracking study.
Zhou D, Yang W, Yang Y, Yin G, Li S, Zhuang B
BMC Cardiovasc Disord. 2022; 22(1):99.
PMID: 35282817
PMC: 8919633.
DOI: 10.1186/s12872-022-02532-w.
Mapping signalling perturbations in myocardial fibrosis via the integrative phosphoproteomic profiling of tissue from diverse sources.
Kuzmanov U, Wang E, Vanderlaan R, Kim D, Lee S, Hadipour-Lakmehsari S
Nat Biomed Eng. 2020; 4(9):889-900.
PMID: 32661320
DOI: 10.1038/s41551-020-0585-y.
The potential roles of Von Willebrand factor and neutrophil extracellular traps in the natural history of hypertrophic and hypertensive cardiomyopathy.
Becker R, Owens 3rd A, Sadayappan S
Thromb Res. 2020; 192:78-87.
PMID: 32460175
PMC: 7340095.
DOI: 10.1016/j.thromres.2020.05.003.
Non-diagnostic autopsy findings in sudden unexplained death victims.
Yazdanfard P, Christensen A, Tfelt-Hansen J, Bundgaard H, Winkel B
BMC Cardiovasc Disord. 2020; 20(1):58.
PMID: 32019512
PMC: 7001247.
DOI: 10.1186/s12872-020-01361-z.
MRI T1 Mapping in Hypertrophic Cardiomyopathy: Evaluation in Patients Without Late Gadolinium Enhancement and Hemodynamic Obstruction.
Xu J, Zhuang B, Sirajuddin A, Li S, Huang J, Yin G
Radiology. 2019; 294(2):275-286.
PMID: 31769741
PMC: 6996717.
DOI: 10.1148/radiol.2019190651.
Ablation of SUN2-containing LINC complexes drives cardiac hypertrophy without interstitial fibrosis.
Stewart R, Rodriguez E, King M
Mol Biol Cell. 2019; 30(14):1664-1675.
PMID: 31091167
PMC: 6727752.
DOI: 10.1091/mbc.E18-07-0438.
Coronary arterial vasculature in the pathophysiology of hypertrophic cardiomyopathy.
Marszalek R, Solaro R, Wolska B
Pflugers Arch. 2018; 471(5):769-780.
PMID: 30370501
PMC: 6481925.
DOI: 10.1007/s00424-018-2224-y.
Allele-specific differences in transcriptome, miRNome, and mitochondrial function in two hypertrophic cardiomyopathy mouse models.
Vakrou S, Fukunaga R, Foster D, Sorensen L, Liu Y, Guan Y
JCI Insight. 2018; 3(6).
PMID: 29563334
PMC: 5926940.
DOI: 10.1172/jci.insight.94493.